KRAS and colorectal carcinoma: By combining our data with previously published data, the present study demonstrated that the SUVmax of 18FDG-PET/CT is different in colon and rectal cancers and is associated with KRAS mutation but not with the Ki-67 index; there was no significant association between the SUVmax and survival of patients with CRC.